期刊
TUMOR BIOLOGY
卷 37, 期 5, 页码 6343-6348出版社
SPRINGER
DOI: 10.1007/s13277-015-4520-x
关键词
IL12 gene; Persistent HBV infection; HBV-related HCC
类别
资金
- Guangxi Natural Science Foundation [2012GXNSFBA053117]
- Guangxi Natural Science Fund for Innovation Research Team [2013GXNSFFA019002]
- Guangxi Collaborative Innovation Center for genomic and personalized medicine [201319]
- Guangxi Natural Science Fund for Distinguished Young Scholars [2012jjFA40011]
- Program for New Century Excellent Talents in University [NCET-12-0653]
IL12 plays a major role not only in inducing appropriate immune responses against viral infections (including HBV) but also in the antitumor immune response. This study was conducted to investigate the relationships of genetic variants in IL12 with hepatitis B virus (HBV) clearance and development of HBV-related hepatocellular carcinoma (HCC). We genotyped three single nucleotide polymorphisms (SNPs) of the IL12A (rs568406 and rs2243115) and IL12B (rs3212227) in 395 HBV-positive HCC patients, 293 persistent HBV carriers and 686 subjects with HBV natural clearance from southern China, using the improved multiplex ligase detection reaction (iMLDR) method. Logistic regression analysis adjusted for age, smoking, and alcohol consumption status showed that rs568408 variant genotypes were significantly associated with host HBV-related HCC risk when compared with persistent HBV carriers, and carriers of the GA+ AA genotype decreased the HCC risk in comparison with GG carriers (adjusted OR=0.53, 95 % CI 0.35-0.80, P=0.002). No relationships between the rs2243115 and rs3212227 SNPs and HCC risk were observed (all P>0.05). Besides, rs568408 showed an approaching significant effect on susceptibility to HBV persistent infection (adjusted OR=1.34, 95 % CI 0.99-1.81, P=0.057 in dominant genetic models). Furthermore, the TG haplotype was observed to be associated with a significantly increased risk of HBV-related HCC (OR=1.42, 95 % CI 1.10-1.83, P=0.006), while TA haplotype was associated with a decreased risk of HBV-related HCC (OR=0.61, 95 % CI 0.45-0.83, P=0.002). Our results reveal that the IL12A rs568408 variant may be a marker SNP for risk of both HBV clearance and HBV-related HCC development.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据